drugset / Trial / NCT02014532

Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis

NCT02014532

Phase 4 Completed 60 enrolled Tatyasaheb Kore Dental College
RandomizedParallel-groupTriple-blindTreatment

Summary

The adjunctive use of Leukotriene Receptor Antagonist (Montelukast) along with scaling and root planing in patients with chronic periodontitis leads to host inflammatory response modulation and decrease in serum C reactive protein (CRP) levels. If proven this will open new vistas in treatment of chronic periodontitis.

Timeline

Start
2012-03
Primary completion
2013-07
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg

Indications